期刊文献+

非小细胞肺癌脑转移综合治疗的疗效分析 被引量:5

Clinical study of combined treatment for brain metastases from non-small cell lung cancer
原文传递
导出
摘要 目的:探讨非小细胞肺癌(NSCLC)脑转移不同治疗方法的疗效分析及预后因素。方法:回顾性分析2001-01-2006-06我科治疗的71例NSCLC脑转移患者,14例行手术+放疗±化疗,26例行单纯放疗,31例行放疗+化疗。42例行全脑放疗±局部加量,29例行全脑放疗+三维适形调强放疗。全部病例定期随访直至死亡,分别行单因素和多因素分析。结果:全组中位生存期为10个月,1、2和3年生存率分别为29.58%(21/71)、16.90%(12/71)和8.45%(6/71)。单因素分析显示,KPS评分、病理类型、脑转移数目、脑转移大小、原发灶控制、中枢外转移、治疗方法、放疗剂量、放疗方式和近期疗效对生存期有影响。多因素分析显示,KPS评分、脑转移数目、原发灶控制、中枢外转移和近期疗效是独立的生存预后因素。结论:NSCLC脑转移的主要预后因素是KPS评分、脑转移数目、原发灶控制、中枢外转移、近期疗效。积极治疗可适当延长生存期。 OBJECTIVE:To examine the efficacy of different treatments on non-small cell lung cancer(NSCLC) with brain metastasis,and evaluate factors affecting the survivals.METHODS:The data of 71 patients from Jan 2001 to Jun 2006 were retrospectively reviewed.Fourteen patients received brain surgery and radiotherapy or chemotherapy,26 patients received single radiotherapy,31 patientsreceived radiotherapy and chemotherapy.Totally 42 patients received whole brain radiotherapy or partly radiotherapy,29 patients received whole brain radiotherapy and three-dimensional conformal radiotherapy.All of these patients were followed up until their death.The Kaplan-Meier method was used to analyze the survial,and Logrank test was used to evaluate the difference between the groups.The cox regessive model was used to analyze the prognostic factors.RESULTS:The overall 1-,2-,and 3-year survival rates were 29.58%(21/71),16.90%(12/71) and 8.45%(6/71) respectively,with a median survival time of 10 months.The single factor analysis showed that KPS,histological type,the number of brain metastasis,the size of brain metastasis,primary disease control,presence of metastasis other than brain,the therapy methods,the doses of radiotherapy,the method of radiotherapy,and the curatived effect to brain cancer metastasis lump recently had an influence to survival period.In multivariate analysis,KPS,the number of brain metastasis,primary disease control,presence of metastasis other than brain,and the curatived effect to brain cancer metastasis lump recently were independent prognostic factors.CONCLUSIONS:The main prognostic factors of brain metastases from NSCLC are KPS,the number of brain metastasis,primary disease control,presence of metastasis other than brain,and the curatived effect to brain cancer metastasis lump recently.The survival is prolonged by proper treatment.
出处 《中华肿瘤防治杂志》 CAS 2010年第24期2049-2052,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 非小细胞肺 脑转移 预后 因素分析 carcinoma non-small cell lung brain metastasis prognosis factors analysis
  • 相关文献

参考文献19

  • 1孙燕,周际昌.临床肿瘤内科手册[M].4版.北京:人民卫生出版社.2004:53-54.
  • 2Bamholtz-Sloan J S, Sloan A E, Davis F G, et al. Incidence proportions of brain metastases in patients diagnosed(1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System[J]. J Clin Oncoi,2004,22(14) :2865-2872.
  • 3Bajard A, Westeel V, Dubiez A, et al. Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma[J].Lung Cancer, 2004,45 (3) : 317-323.
  • 4Coia L R. The role of radiation therapy in the treatment of brain metastases[J]. Int J Radiat Oncol Biol Phys, 1992,23 ( 1 ) : 229- 238.
  • 5Gaspar L, Scott C, Rotman M, et al. Recursive partitioning a nalysis(RPA) of prognostic factors in three Radiation Therapy Oncology Group(RTOG)brain metastases trials[J]. Int J Radiat Oncol Biol Phys,1997,37(4),745-751.
  • 6West J, Maor M. Intracranial metastases : behavioural patterns related to primary site and result of treatment by whole brain irradiation[J].Int J Radiat Oncol Biol Phys, 1980,6 (1) : 11-15.
  • 7Noordijk E M,Vecht C J, Haaxma-Reiche H,et ah The choice of treatment of single brain metastasis should be based on extracra- nial tumor activity and age[J].Int J Radiat Oncol Biol Phys, 1994,29(4) :711-717.
  • 8Westphal M, Heese O, de Wit M. Intracranial metastases therapeutic options[J]. Ann Oncol, 2003,14(Suppl 3) :4-10.
  • 9Murray K J,Scott C, Greenberg H M, et al. A randomized phase Ⅲ study of accelerated hyperfraetionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oneology Group(RTOG) 9104[J]. Int Radiat Oneol Biol Phys, 1997, 39(3) :571-574.
  • 10O'Neill B P,Iturria N J,Link M J,et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases[J]. Int J Radiat Oncol Biol Phys, 2003, 55(5) : 1169-1176.

共引文献12

同被引文献41

  • 1AndrewsDW ScottCB SperdutoPW FlandersAE GasparLE SchellMC Werner-WasikM DemasW RyuJ BaharyJP SouhamiL RotmanM MehtaMP CurranWJJr.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ resuIts of the RTOG 9508 randomised trial[J].中国神经肿瘤杂志,2004,2(3):192-192. 被引量:225
  • 2胡胜,杨玲,谭文勇,柯玉华,李密,宋启斌.肺癌脑转移的时间分布和生存分析[J].中国肿瘤,2007,16(12):1027-1030. 被引量:3
  • 3LIU HH, WANG X,DONG L,et al. Feasibility of sparing lung andother thoracic structures with intensity - modulated radiotherapy fornon - small - cell lung cancer [ J ]. Int J Radiat Oncol Biol Phys,2004,58(4) ;1268 -1279.
  • 4BORRAS JM,FERNANDEZ E,GONZALEZ JR,et al. Lung cancermortality in European regions [ J ] . Ann Oncol, 2003,14:159 -161.
  • 5SONAL S,VISHAL G,ELLENY,et al. Intensity - modulated radi-ation therapy for inoperablenon - small cell caneer : the MemorialSloan - Kettering Cancer Center experience [ J ]. Radiother Oncol,2008,87(1) :17 -23.
  • 6RENGAN R,HOSENZWEIG KE, VENKATRAMAN E. Improvedlocal control with higher doses of radiation in large - volume stageIII non - small - cell lung cancer [ J ]. Int J Radiat Oncol BiolPhys2004,60(3) :741 -747.
  • 7Jun ichi S, Yoshihiro S, Tomoko K, et al. Therapeutic Effect of Lin- ac-based Stereotactic Radiotherapy with a Micro-multileaf Collima- tor for the Treatment of Patients with Brain Metastases from Lung Cancer[J].Jpn J Clin Oncol,2010,40(2) : 119-124.
  • 8Fiorino C, Cozzarini C, Rancati T, et al. Modelling the impact of fraction- ation on late urinary toxicity after postprostatectomy radiation therapy [J]. Int J Radiat Oncol Biol Phys, 2014,90(5) : 1250- 1257.
  • 9Englander Z A, Sun J, Laura C, et al. Brain structural connectivity increases concurrent with functional improvement: Evidence from diffusion tensor MRI in children with cerebral palsy during therapy [J].NeuroimageClin,2015 (7) :315- 324.
  • 10Pavy J J,Denekmp J, Lelschefl J, et al. EORTC late Effecte Work- ing Group. Late Effects toxicity scoring: the SOMA scale[J]. Int J Radiat Oncol Biol Phys, 1995,31(5) : 1043- 1047.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部